Press releases
- GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient (dMMR) solid cancers at ASCO Gastrointestinal Cancers Symposium
- Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19
- Vir Biotechnology and GSK announce start of NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalised adults with COVID-19
Tweets from GSK US
-
GSKUS @GSKUS
#News for #media and #investors: We are presenting new data from our oncology pipeline at #GI21. Visit gsk.to/38LP6sm for more information.
about 16 hours ago
-
GSKUS @GSKUS
Whether it be an in-person or #telehealth appointment, writing down notes prior to a #COPD check-up can help people with COPD remember to inform their doctor about any changes in their symptoms or disease management. Before an appointment, write down these five things.👇
about 2 days ago -
GSKUS @GSKUS
After a strong 2020, our Chief Scientific Officer & R&D President Hal Barron shared more about how we are poised for 2021 at #JPM2021. Learn more here:
about 3 days ago
